Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
29,844,757
-
Share change
-
+763,979
-
Total reported value
-
$16,471,622
-
Put/Call ratio
-
227%
-
Price per share
-
$0.5492
-
Number of holders
-
69
-
Value change
-
+$130,758
-
Number of buys
-
32
-
Number of sells
-
35
Institutional Holders of iBio, Inc. - Common Stock (IBIO) as of Q4 2021
As of 31 Dec 2021 iBio, Inc. - Common Stock (IBIO) had 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 29,844,757 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Nuveen Asset Management, LLC, Bank of New York Mellon Corp, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, GOLDMAN SACHS GROUP INC, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 70 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.